Activities per year
Activities
- 150 - 193 out of 193 results
Search results
-
Beeak-out Medical: Hemostasis and update on the Post Authorization Safety Study
Jonathan Douxfils (Speaker) & Guillaume Chatel (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Method validation for haemostasis assays: Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women. An unmet clinical and regulatory need
Jonathan Douxfils (Speaker)
15 Sept 2022Activity: Talk or presentation types › Invited talk
-
Linking platelet lipid metabolism and thrombosis: Role of acetyl-CoA carboxylase
Jonathan Douxfils (Jury Member)
25 Aug 2022Activity: Examinations › External Thesis
-
ISTH 2022 Congress
Jonathan Douxfils (Contributor)
9 Jul 2022 → 13 Jul 2022Activity: Participating in or organising an event types › Participation in conference
-
ISTH 2022 Congress
Laure Morimont (Participant), Marie Didembourg (Participant) & Jonathan Douxfils (Participant)
9 Jul 2022 → 13 Jul 2022Activity: Participating in or organising an event types › Participation in conference
-
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
Jonathan Douxfils (Speaker)
4 Jul 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
7 Jun 2022Activity: Talk or presentation types › Invited talk
-
Monitoring des anticoagulants: Artéfacts ou avantages - Anticoagulants directs oraux
Jonathan Douxfils (Speaker)
20 Jun 2022Activity: Talk or presentation types › Invited talk
-
L’associazione Estetrolo/Drospirenone: approfondimento sui parametri ematocoagulativi | Why APC resistance matters?
Jonathan Douxfils (Speaker)
14 Jun 2022Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: recent clinical evidence
Jonathan Douxfils (Speaker)
12 May 2022Activity: Talk or presentation types › Invited talk
-
11ème symposium annuel du NTHC(Namur Thrombosis & Hemostasis Center)
Laure Morimont (Contributor), Jonathan Evrard (Contributor), Romain Siriez (Contributor), Jonathan Douxfils (Contributor), Marie Didembourg (Participant), Constant GILLOT (Participant), Happy Djokoto (Participant) & Helene Haguet (Participant)
17 May 2022Activity: Participating in or organising an event types › Participation in conference
-
16th ESC congress
Laure Morimont (Participant) & Jonathan Douxfils (Contributor)
25 May 2022 → 28 May 2022Activity: Participating in or organising an event types › Participation in conference
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
17 May 2022Activity: Talk or presentation types › Invited talk
-
Estetrol (E4): a native estrogen whose effect on the liver does not need to be counterbalanced by progestins
Jonathan Douxfils (Speaker)
27 May 2022Activity: Talk or presentation types › Oral presentation
-
Correlation between activated protein C Resistance and the Relative Risk of Venous Thromboembolism in Women Using Hormonal Therapy
Laure Morimont (Speaker) & Jonathan Douxfils (Speaker)
11 May 2022 → 14 May 2022Activity: Talk or presentation types › Oral presentation
-
10 ans de monitoring des anticoagulants oraux. Où en sommes-nous et où allons-nous?
Jonathan Douxfils (Speaker)
15 Mar 2022Activity: Talk or presentation types › Invited talk
-
Estétrol/drospirénone, le point de vue de l’hém(ost)ato(sio)logue
Jonathan Douxfils (Speaker)
26 Jan 2022Activity: Talk or presentation types › Invited talk
-
Impact of progestagen alone or associated with estrogen on the coagulation: A state of the art in 2023
Jonathan Douxfils (Speaker)
1 Dec 2023Activity: Talk or presentation types › Invited talk
-
Innovative applications of global assays in hemostatis
Jonathan Douxfils (Jury Member)
15 Dec 2023Activity: Examinations › External Thesis
-
Safety profile of E4 Recent advance and evidence
Jonathan Douxfils (Speaker)
14 Nov 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4 Recent advance and evidence
Jonathan Douxfils (Invited speaker)
7 Nov 2023Activity: Talk or presentation types › Invited talk
-
Hemostasis parameters with estetrol/drospirenone - why APC resistance matters
Jonathan Douxfils (Speaker)
30 Nov 2023Activity: Talk or presentation types › Invited talk
-
Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model
Laure Morimont (Speaker) & Jonathan Douxfils (Speaker)
30 Nov 2023Activity: Talk or presentation types › Oral presentation
-
Navigating new regulations in biobanking for clinical studies and research projects
Jonathan Douxfils (Speaker)
4 Oct 2023Activity: Talk or presentation types › Oral presentation
-
Combined Hormonal Contraceptives - Induced Coagulopathies Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Jonathan Douxfils (Speaker) & Laure Morimont (Speaker)
4 Oct 2023Activity: Talk or presentation types › Invited talk
-
-
FIGO - XXIVe World Congress of Gynecology and Obstetrics
Jonathan Douxfils (Speaker)
9 Oct 2023 → 13 Oct 2023Activity: Participating in or organising an event types › Participation in conference
-
Donesta Partner Meeting : Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Jonathan Douxfils (Keynote speaker)
4 Sept 2023 → 8 Sept 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: Recent advance and evidence
Jonathan Douxfils (Keynote speaker)
18 Sept 2023Activity: Talk or presentation types › Invited talk
-
Aquired APC-resistance as a marker for VTE, how reliable?
Jonathan Douxfils (Invited speaker)
27 Aug 2023Activity: Talk or presentation types › Invited talk
-
Évaluation du risque vasculaire des contraceptifs
Jonathan Douxfils (Invited speaker)
21 Jun 2023 → 23 Jun 2023Activity: Talk or presentation types › Invited talk
-
Risque induit par les oestrogènes de synthèse en clinique
Jonathan Douxfils (Invited speaker)
8 Jun 2023Activity: Talk or presentation types › Invited talk
-
APC resistance as a marker of the risk of VTE in users of oral contraceptives. Practical usefulness for industry and for clinicians
Jonathan Douxfils (Invited speaker)
26 May 2023Activity: Talk or presentation types › Invited talk
-
Fantastic 4 - E4stetrol in Women's Health
Jonathan Douxfils (Invited speaker) & Jean-Michel Foidart (Invited speaker)
4 May 2023 → 6 May 2023Activity: Talk or presentation types › Oral presentation
-
Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Jonathan Douxfils (Invited speaker)
24 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Estétrol: une nouvelle ère dans la contraception
Jonathan Douxfils (Invited speaker)
11 Feb 2023Activity: Talk or presentation types › Invited talk
-
Thromboembolie veineuse et contraception orale: Quelle stratégie pour minimiser le risque?
Jonathan Douxfils (Invited speaker) & Laure Morimont (Speaker)
12 Jan 2023Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Jonathan Douxfils (Speaker)
16 Mar 2024Activity: Talk or presentation types › Invited talk
-
Innovative biomarkers in sepsis
Jonathan Douxfils (Speaker)
28 Mar 2024Activity: Talk or presentation types › Invited talk
-
Cardiovascular safety: the point of view of the veins
Jonathan Douxfils (Speaker)
8 Mar 2024Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Jonathan Douxfils (Speaker)
22 Feb 2024Activity: Talk or presentation types › Invited talk
-
Rencontre Université de Namur - Faculté de Médecine et Clinique Saint-Luc de Bouge
Jonathan Douxfils (Contributor)
15 Feb 2024Activity: Participating in or organising an event types › Participation in workshop, seminar, course
-
Hormones-induced Coagulopathies — Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Jonathan Douxfils (Speaker)
25 Jan 2024Activity: Talk or presentation types › Invited talk